The Association of SGLT2i vs DPP4i on Fracture: A Cohort Study in Veterans with Diabetes
SGLT2i use as add-on treatment for diabetes was not associated with increased fracture outcomes compared to DPP4i.
Authors
- Amber J. Hackstadt (ORCID: https://orcid.org/0000-0002-0164-6589)
- Kathryn Snyder
- Christianne L. Roumie (ORCID: https://orcid.org/0000-0002-6555-2055)
- Adriana M. Hung (ORCID: https://orcid.org/0000-0002-3203-1608)
- Robert A. Greevy (ORCID: https://orcid.org/0000-0002-1821-3544)
- Amir Javid (ORCID: https://orcid.org/0000-0002-3698-1803)
- Katherine Griffin
Institutions
- Vanderbilt University (US)
- VA Tennessee Valley Healthcare System (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- American Journal of Medicine Open
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1016/j.ajmo.2025.100105
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00